Measurement contract · updated 2026-09-13
Methodology
ElementalDose applies 15 explicit salt models and 5 evidence tiers to filed magnesium labels, using the registry snapshot dated 2026-08-10 and the calculation contract updated 2026-09-13.
01 · declarations and arithmetic
What the registry declares and what we compute
A declaration of 100 mg elemental magnesium corresponds to 165.78 mg magnesium oxide, using its 60.32% magnesium fraction in the calculation contract dated 2026-09-13; the element and its carrier are different masses.
| Quantity | Source or operation | What the number describes |
|---|---|---|
| Elemental magnesium | 100 mg in the worked example | The mass of magnesium atoms declared in the nutrient line, without the rest of the salt. |
| Magnesium oxide fraction | 60.32% from MgO | The elemental part of the reference compound’s mass. |
| Magnesium oxide compound mass | 100 ÷ 0.6032 = 165.78 mg | The total salt mass needed to carry the example’s elemental amount. |
| Elemental magnesium per container | Elemental mg per serving × servings | The sum over the filed container; neither absorbed amount nor compound weight. |
| Compound mass per unit | Compound mg per serving ÷ discrete units per serving | The inferred mass in each capsule, tablet or other countable unit. |
| EC100 | Container price ÷ (elemental mg per serving × servings ÷ 100) | USD per 100 mg declared elemental magnesium in a matched package. |
The NIH Dietary Supplement Label Database is our source of label declarations. The primary magnesium row supplies the amount; a separate name identifies the chemical carrier. Taking the nutrient amount as the compound amount would reduce it a second time and produce the wrong elemental total. The conversion on this site runs in the other direction: from the declared element to the mass of the named salt required to carry it. See the NIH DSLD registry and the mineral declaration rules in 21 CFR 101.36.
The retained primary serving is the lowest serving-order magnesium entry after rows for other nutrients supplied by magnesium salts have been excluded. Repeated equal amounts collapse to one elemental value. Where distinct amounts remain, the explicit magnesium or elemental wording can resolve the primary amount; otherwise the amount is ambiguous. A magnesium salt named under vitamin C, for example, does not make the vitamin C quantity an elemental magnesium measurement.
Container arithmetic requires a positive numeric serving count. We keep a filed serving count even when dividing net contents by serving size would yield a slightly different number: rounded grams and rounded portions can disagree. The package block shows both filed inputs so the difference remains inspectable. For powders and liquids, a serving expressed in mg or mL is a measure of mass or volume, not a count of capsules.
We retain a label identifier throughout the calculation chain. Brand and product names are for human identification; the integer DSLD identifier is the stable join key within this release. A new version of a brand’s label is not automatically the same package as an older version, even when the front-facing name is unchanged.
02 · explicit chemical inputs
Elemental fractions by salt
The salt model contains 15 reference compounds as of 2026-09-13, with elemental fractions from 5.86% for gluconate to 60.32% for oxide; every configured hydrate ambiguity is carried through as a range.
| Salt | Reference formula | Reference molar mass (g/mol) | Elemental fraction | Compound mg per 100 mg elemental | Range basis |
|---|---|---|---|---|---|
| Magnesium oxide | MgO | 40.30 | 60.32% | 165.78 | One reference composition in the model dated 2026-09-13; no hydration interval configured. |
| Magnesium hydroxide | Mg(OH)₂ | 58.32 | 41.68% | 239.92 | One reference composition in the model dated 2026-09-13; no hydration interval configured. |
| Magnesium carbonate | MgCO₃ | 84.31 | 24.78–28.83% | 346.86–403.55 | anhydrous or hydrated; labels rarely state which |
| Magnesium chloride | MgCl₂ | 95.21 | 11.96–25.53% | 391.7–836.12 | anhydrous 25.5%, hexahydrate 12.0% |
| Magnesium sulfate | MgSO₄ | 120.37 | 9.86–20.19% | 495.29–1,014.2 | anhydrous 20.2%, heptahydrate 9.9% |
| Magnesium citrate | Mg₃(C₆H₅O₇)₂ | 451.11 | 11.3–16.16% | 618.81–884.96 | trimagnesium dicitrate 16.2%; dibasic and hydrated forms as low as 11.3% |
| Magnesium malate | MgC₄H₄O₅ | 156.38 | 13.2–15.54% | 643.5–757.58 | anhydrous or dihydrate |
| Magnesium glycinate | Mg(C₂H₄NO₂)₂ | 172.42 | 11.83–14.1% | 709.22–845.31 | bisglycinate; chelate hydration varies by supplier |
| Magnesium glycerophosphate | MgC₃H₇O₆P | 194.36 | 12.5% | 800 | One reference composition in the model dated 2026-09-13; no hydration interval configured. |
| Magnesium lactate | Mg(C₃H₅O₃)₂ | 202.45 | 12.01% | 832.64 | One reference composition in the model dated 2026-09-13; no hydration interval configured. |
| Magnesium taurate | Mg(C₂H₆NO₃S)₂ | 274.58 | 8.85% | 1,129.94 | One reference composition in the model dated 2026-09-13; no hydration interval configured. |
| Magnesium aspartate | Mg(C₄H₆NO₄)₂ | 288.50 | 8.42% | 1,187.65 | One reference composition in the model dated 2026-09-13; no hydration interval configured. |
| Magnesium L-threonate | Mg(C₄H₇O₅)₂ | 294.50 | 8.25% | 1,212.12 | One reference composition in the model dated 2026-09-13; no hydration interval configured. |
| Magnesium orotate | Mg(C₅H₃N₂O₄)₂ | 334.49 | 7.27% | 1,375.52 | One reference composition in the model dated 2026-09-13; no hydration interval configured. |
| Magnesium gluconate | Mg(C₆H₁₁O₇)₂ | 414.60 | 5.86% | 1,706.48 | One reference composition in the model dated 2026-09-13; no hydration interval configured. |
The reference fraction is the mass of magnesium atoms in a formula unit divided by the molar mass of that formula unit. Magnesium’s atomic mass is taken as 24.305 g/mol. A formula with three magnesium atoms uses three times that atomic mass in its numerator. The displayed molar mass belongs to the stated reference formula; it is not a claim that every commercial material with that salt name has exactly that hydration state.
The code stores rounded fractions rather than recalculating them from the displayed rounded molar masses. Published arithmetic uses those stored fractions consistently, so a reader dividing two rounded display values can see a small rounding difference. We expose the fraction as well as the formula to make that distinction reproducible. Salt fractions characterize compounds; they do not measure a product’s absorption or establish a product ranking.
When the magnesium fraction ranges from f_low to f_high, the compound mass ranges from elemental mg ÷ f_high to elemental mg ÷ f_low. The inversion matters: the larger magnesium fraction gives the smaller required compound mass. We preserve both endpoints in the label CSV and JSON, the card’s mass table and its per-unit metadata. Taking the midpoint would conceal a physical ambiguity that the label has not resolved.
The “Range basis” column reproduces each salt’s configured ambiguity. For chloride and sulfate, water of crystallization changes the mass without adding magnesium. Citrate also covers differences in the named citrate composition. A single reference value elsewhere in the table means that the current model contains one composition, not that all possible commercial hydrates have been ruled out. The model’s chemical coverage is narrower than the vocabulary found in supplement marketing.
“Bisglycinate” and recognized spelling variants resolve to the glycinate key. “Amino acid chelate” does not identify a formula and receives no invented elemental fraction. A mixture needs constituent proportions before its total compound mass can be determined. A name match is therefore a declared-source interpretation, not a chemical assay of the bottle.
03 · a physical constraint with stated assumptions
Mass budget and capsule capacities
The capsule model compares the smallest required compound mass against 3 capacities—545, 730 and 1,100 mg—at powder density 0.6–0.8 g/mL, using the calculation contract dated 2026-09-13.
| Capsule size | Powder capacity | Density assumption |
|---|---|---|
| 0 | 545 mg | powder density 0.6–0.8 g/mL |
| 00 | 730 mg | powder density 0.6–0.8 g/mL |
| 000 | 1,100 mg | powder density 0.6–0.8 g/mL |
Compound mg per serving = declared elemental mg ÷ elemental fraction
Compound mg per unit = compound mg per serving ÷ units per serving
The test takes the most favourable supported interpretation for the product: the highest elemental fraction and therefore the smallest compound mass. For a hydration interval, this is the low endpoint of the compound-mass interval. The capacity comparison does not take the midpoint and does not use the largest required mass to manufacture an exceedance.
| Verdict | Favourable compound mass per unit | Published conclusion |
|---|---|---|
| fits-0 | ≤ 545 mg | fits a size 0 capsule (holds about 545 mg) |
| needs-00 | > 545 mg and ≤ 730 mg | requires at least a size 00 capsule (a size 0 holds about 545 mg) |
| needs-000 | > 730 mg and ≤ 1,100 mg | requires the largest standard size, 000 (holds about 1,100 mg) |
| exceeds-all | > 1,100 mg | exceeds every standard capsule size — the largest, 000, holds about 1,100 mg |
| not-applicable | A physical state outside the capsule model | No capsule-capacity verdict is inferred for a tablet, powder or liquid. |
The conclusion on an exceeding product page is conditional: “If the declared salt were the sole source of magnesium here,” the minimum powder mass would exceed the standard capsule capacity. The resulting statement is: “So the label does not establish” the named salt “as the only source.” The fixed boundary of that conclusion is: “This is a statement about the label's arithmetic, not about what is in the bottle.” These are the same distinctions used in the product mass-budget component.
The mass budget is not a fill-weight measurement. Powder packing, particle size and density affect the weight a capsule can hold. The model uses the project’s deliberately generous approximate capacities; it does not infer an actual capsule dimension from a product photo. A denser blend, a non-standard capsule or a different physical interpretation of the label can change the result. The label would need additional information to distinguish those cases.
The mass of other ingredients and the capsule shell is excluded. Their quantities are usually not given in the retained record, and adding assumed amounts would make the model less favourable without adding evidence. A passing result therefore means that the salt mass clears this particular bound. It does not prove that every ingredient and the shell have been physically reconciled.
The downloadable audit is exactly the union of exceeds-all and needs-000 records. Both groups are computed from the same budget object as the product cards. The counts and product lists for the whole corpus live in the label audit. A product card carries its own result and the constants needed to interpret it.
04 · provenance travels with the value
Evidence tiers
Every new product measurement uses 1 of 5 evidence tiers as of 2026-09-13, separating a source observation, a calculation, a physical model, a proxy and a same-salt benchmark.
| Tier | Meaning | Example | Interpretation |
|---|---|---|---|
| observed | A value transcribed from a named source at a recorded date. | Elemental milligrams on a filed label, a barcode, an observed USD item price, a study endpoint. | The source can itself contain errors. Observed does not mean independently measured by ElementalDose. |
| computed | A deterministic transformation of identified inputs. | Elemental mass per container; compound mass from a salt fraction; EC100; a within-salt percentile. | The result inherits the scope and precision of the inputs. A multiplication does not resolve an uncertain identity. |
| modelled | A result conditional on an explicit assumption about the physical system. | The fit verdict at a specified powder density and standard capsule capacity. | A capsule can have a different density, volume or mixture. The model establishes a conditional mass constraint. |
| proxy | An observed quantity used to stand in for another quantity that was not measured directly. | Urinary magnesium excretion used by a cited study to examine absorption. | A change in the proxy is not a numerical measurement of every process it can reflect. |
| benchmark | A calculation transferring a group reference to a specific unpriced package. | Same-salt median EC100 multiplied by this label’s elemental package mass. | A benchmark is not a retailer quote, an offer, or an observed price for that product. |
These tiers are kinds of evidence, not a ladder of numerical confidence scores. A computed value can be exact conditional on a doubtful input. An observed value can be a faithful transcription of an inaccurate label. A benchmark can be correctly calculated without being a plausible current retail quote. The label attached to the result says how it was obtained, while the accompanying sentence identifies the source and date.
On product cards, the evidence tier appears beside each structured measurement in the visible table. The Product JSON-LD repeats the same value and puts the tier in valueReference. Compound mass per unit is computed; the fill verdict and required capsule size are modelled. The first product sentence is also used verbatim as the Product description. That keeps the machine-readable claim attached to the same subject, unit and date as the visible claim.
Missing evidence is a dated statement. “No confirmed retail price as of 2026-09-13” differs from a zero-dollar price. “No standard size fits” differs from an unrecorded capsule size. The exports retain those distinctions in text instead of empty cells. Analysts can select numeric observations by type in JSON or by excluding the documented missing-data statements in CSV.
| Field | Tier | Definition |
|---|---|---|
| dsld_id | observed | Integer NIH label identifier; the join key for the source record, product page and price observation. |
| brand / name | observed | Filed identity text. Brand spelling is retained in downloads; a normalized brand token is used only in the search gate. |
| physical_state | observed | Capsule, tablet, powder, liquid or another filed state. The capsule model is applied only to records classified as capsules. |
| salt / salt_source | computed / observed | Normalized single salt and its source: label-row or full-record. Unresolved means no single supported conversion has been selected. |
| elemental_mg_serving | observed | The selected primary magnesium amount from the label, in milligrams of the element, not the whole compound. |
| servings | observed | Positive numeric servings per container as filed. A missing count is not reconstructed from an unrelated retail pack. |
| elemental_mg_container | computed | Elemental milligrams per primary serving multiplied by filed servings per container. |
| compound_mg_serving_low / high | computed | The elemental amount divided by the highest / lowest supported magnesium fraction. The two numbers remain separate columns. |
| compound_mg_per_unit | computed | Mass per discrete capsule, tablet or similar countable unit. A hydration range is exported as low–high, in mg, using the selected serving’s minimum unit count. |
| fill_verdict | modelled | fits-0, needs-00, needs-000, exceeds-all or not-applicable; unavailable calculations carry a dated explanation. |
| required_capsule_size | modelled | 0, 00 or 000 for the smallest standard size that passes the favourable-bound comparison; no standard size fits is explicit. |
| has_stearate | observed | Whether the available other-ingredient text names magnesium stearate. False describes that text, not a laboratory absence test. |
| capsule_material | computed | gelatin or vegetarian from filed ingredient names; no material is inferred solely from marketing imagery. |
| target_groups | observed | The registry’s target-group strings joined by |. These are manufacturer-filed categories. |
| upc | observed | Barcode preserved as text, including leading zeros. It is not a successful retail match by itself. |
| label_date / version_count | observed | The label’s own date and the count of versions held in the enrichment record; a count contains no change details. |
| price_usd / price_observed_at | observed | The retained USD observation and its original timestamp, populated for the publication confidence gate only. |
| ec100_usd | computed | Observed container price divided by the number of 100 mg elemental units in the matched label’s package. |
| match_confidence | computed | confirmed, candidate, legacy-verified, legacy-provisional or unmatched; a legacy status is never silently upgraded. |
| snapshot_date / derived_date | observed / computed | The registry snapshot date and date of the calculation contract. Rebuilding a page is not a new price observation. |
The daily-value calculation uses the declared elemental amount and a reference for the filed group. The package-duration calculation uses the label’s own frequency. Neither is personalized to a visitor. The arithmetic can be reproduced from its inputs without interpreting a target-group declaration as a finding about that group.
05 · identify the product before dividing its price
Price matching
The last logged price-matching run processed 283 eligible labels, examined 13,842 search candidates and recorded 0 new priced matches on 2026-09-13, according to the final entry in the retained price-match log.
| Log field | Value | Meaning |
|---|---|---|
| processed | 283 | Labels processed in this run. |
| eligible | 283 | Labels meeting this run’s search requirements. |
| candidates | 13,842 | Search results examined; not unique accepted products. |
| gated | 13 | Matches reaching the retrieval stage after identity screening. |
| priced | 0 | New priced matches written by this run. |
| candidates_saved | 12 | Unconfirmed candidates retained for review. |
| spent_usd | $0.9989 | Reported provider spend for the run. |
| budget_usd | $4.00 | Run budget, not product price. |
The query is brand + “magnesium” + resolved salt. Amazon search results are retrieved through DataForSEO’s Merchant API; a product request supplies the price observation. The retained run identifies its search source as dataforseo_merchant_amazon_products_live_advanced and its price source as dataforseo_merchant_amazon_asin_live_advanced. A search title is candidate evidence, not a purchase link or a price guarantee.
Brand and salt are hard gates. A matching milligram number cannot rescue the wrong brand or the wrong salt. After those gates, milligrams determine confidence: a title amount within ±6% of the elemental serving amount, or within ±15% of the reference compound amount, is marked confirmed. A title with no milligram amount, or with an amount outside both tolerances, remains a candidate. The current compound gate uses the high-fraction reference endpoint; it is not a complete hydrate-identity test.
| State | Meaning | Publication behaviour in these cards and downloads |
|---|---|---|
| confirmed | Brand and salt passed; title milligrams passed the elemental or compound tolerance. | Price and EC100 are published with their observation date. |
| candidate | Brand and salt passed but milligrams are absent or do not reconcile. | No product price, percentile input or benchmark input is published from this match. |
| legacy-verified | An older record has a completed-review flag but no explicit current confidence field. | The old status is retained; this release does not silently turn it into confirmed. |
| legacy-provisional | An older record still has the review-needed flag and no current confidence field. | The status is retained; its price is withheld by the current publication gate. |
| unmatched | No retained gold-set match for this label. | A dated absence statement replaces a price. |
Confirmed is a result of this automated identity gate; it is not a synonym for manual review. The stored match_review_needed flag describes a separate review process. In particular, a title can match brand, salt and milligrams while naming a different pack size. The published EC100 divides the observed item price by the DSLD package amount, so a pack-size mismatch remains a material limitation until the package identity is checked.
Barcode search was tested on 2026-09-11 and did not provide a usable identity gate: Google Shopping returned jeans and a garden chair for barcode queries. That observation explains why the matcher uses brand and salt. It does not establish that barcodes never work or that those unrelated search results are supplement offers. The source barcode remains visible for independent checking; a failed search is recorded as our missing match, not as evidence of market absence.
A published observation uses the one-time item price in USD. Coupons, subscription offers, member-only discounts, shipping and tax are outside the price contract. The observed date stays attached to the amount. We do not change it to the build date, infer inventory from a stored price, or treat a retained search result as a live offer.
EC100 is compared only within one salt. The percentile is the percentage of eligible observations at or below the product’s own EC100, including itself; equal values receive equal percentiles. Fewer than three eligible observations produces an explicit small-group statement. For an unpriced label, a benchmark requires a resolved salt, a computed elemental package total and at least three eligible prices in that salt. The same median and cohort feed the benchmark table and sentence.
06 · check the label’s own arithmetic
Percent daily value
The magnesium reference for adults and children aged 4 years and older is 420 mg under 21 CFR 101.9(c)(8)(iv); the 4 group references below are used by the calculation contract dated 2026-09-13.
| Group | Reference | Example: 100 mg elemental |
|---|---|---|
| Adults and children 4 years and older | 420 mg | 24% after whole-percent rounding |
| Infants through 12 months | 75 mg | 133% after whole-percent rounding |
| Children 1 through 3 years | 80 mg | 125% after whole-percent rounding |
| Pregnant and lactating women | 400 mg | 25% after whole-percent rounding |
Percent daily value = elemental magnesium per serving ÷ the applicable group reference × 100. The table reports the original declared percentage, the reference amount, the recomputed whole percentage and the absolute difference in percentage points. It checks a declaration against an explicit reference; it does not turn that reference into an instruction to a reader. Sources: 21 CFR 101.9 and the FDA daily-value table.
The group name must identify a supported reference. A filed “children less than 4 years” category does not distinguish infants from children aged one through three; the page therefore shows an unresolved reference instead of silently using the adult value. A historical label can also use an earlier daily-value convention. Its difference from the current reference is an arithmetic comparison, not a conclusion that the historical filing violated its contemporary rules.
The enrichment record can contain entries from several serving sizes. The card states that its recomputation uses the primary serving. Repeated group entries remain visible as filed, rather than being averaged into a percentage with no corresponding label line. A serving-level comparison requires the original serving-order association; an unresolved association limits the interpretation of a difference.
07 · published measurements with named endpoints
Published absorption studies
The literature set contains 16 studies with PMID, title, journal and year checked against PubMed on 2026-09-11, retained in the release dated 2026-09-13 with each study’s design and limits.
| PMID / year | Title and journal | Design | Limits |
|---|---|---|---|
| 11794633 2001 | Bioavailability of US commercial magnesium preparations Magnesium Research | Four commercially available US preparations given to healthy volunteers; bioavailability measured as the increment in urinary magnesium excretion. | Healthy volunteers, small sample, urinary excretion as a proxy for absorption rather than a direct measurement of retention. |
| 14596323 2003 | Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study Magnesium Research | Randomised, double-blind, placebo-controlled parallel study in 46 healthy individuals, 300 mg of elemental magnesium per day, comparing an amino-acid chelate, citrate and oxide. | 46 participants, healthy, 300 mg per day; “amino-acid chelate” is a class rather than one defined compound, so the chelate arm is not a single substance. |
| 2407766 1990 | Magnesium bioavailability from magnesium citrate and magnesium oxide Journal of the American College of Nutrition | In vitro solubility of 25 mmol of each salt across hydrochloric acid concentrations mimicking achlorhydric to peak acid secretion, plus in vivo gastrointestinal absorbability. | Solubility in a beaker is not absorption in a person; the in vivo arm is small. Published 1990. |
| 7815675 1995 | Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection JPEN: Journal of Parenteral and Enteral Nutrition | Comparison of magnesium diglycinate (a chelate) with magnesium oxide in patients who had undergone ileal resection. | Patients after ileal resection are a specific clinical population with poor absorption to begin with; results do not transfer to people with an intact gut. |
| 22433473 2012 | Comparison of magnesium status using X-ray dispersion analysis following magnesium oxide and magnesium citrate treatment of healthy subjects Magnesium Research | Oral magnesium citrate versus magnesium oxide in healthy subjects; intracellular magnesium measured by X-ray dispersion analysis, alongside platelet function. | Healthy subjects, small sample; intracellular magnesium by X-ray dispersion is not a routine clinical measure. |
| 16548135 2005 | Study of magnesium bioavailability from ten organic and inorganic Mg salts in Mg-depleted rats using a stable isotope approach Magnesium Research | Eighty male Wistar rats fed a magnesium-depleted diet for three weeks, then randomised into ten groups, each receiving a different magnesium salt labelled with a stable isotope. | Rats, not people, and magnesium-depleted rats at that: depletion itself raises absorption. The breadth of the comparison is its value; the species is its limit. |
| 30761462 2020 | Dose-Dependent Absorption Profile of Different Magnesium Compounds Biological Trace Element Research | Absorption of several magnesium compounds profiled across doses rather than at a single dose. | Compound coverage and sample size vary by arm; read the paper before carrying any single figure across. |
| 2299712 1990 | Effect of magnesium citrate and magnesium oxide on the crystallization of calcium salts in urine The Journal of Urology | Seven normal subjects and four patients with recurrent calcium oxalate stones; 486 mg of magnesium per day for two weeks, taken on an empty stomach and again with food. | Eleven subjects; the endpoint is urinary chemistry in stone formers, not absorption in general. Published 1990. |
| 42091979 2026 | Randomized, open-label study of the short-term pharmacokinetics of oral magnesium oxide in healthy volunteers. Scientific reports | Randomized, open-label pharmacokinetic study in 24 healthy male volunteers aged 18-45 years, equally assigned to a single oral dose of either 750 mg or 2000 mg magnesium oxide. | Male volunteers only, no female data; only two dose levels tested (750 mg, 2000 mg) so dose-proportionality across a wider range is not established; terminal elimination parameters (t1/2, AUC0-infinity, CL/F, MRT) could not be estimated within the 12-hour sampling window; single-dose (not chronic) administration; sample size n=24 (12 per dose group). |
| 40955524 2025 | Comparing the Bioavailability of Two Seawater-Derived Magnesium Preparations. Journal of medicinal food | Double-blind, randomized, three-arm crossover study in 20 healthy young men and women: placebo (maltodextrin), seawater-derived magnesium citrate (Aquamin-Mg, minimum 10% elemental magnesium), and seawater-derived magnesium hydroxide (Aquamin-MgTg, minimum 33% elemental magnesium). Total magnesium doses were standardized to the RDA for elemental magnesium. | Small sample (n=20); healthy young adults only, not a magnesium-deficient or older population; only two seawater-derived preparations plus placebo were tested, no head-to-head comparison against standard magnesium citrate/oxide/glycinate salts; short observation window (18 h urine, 2 h serum). |
| 39770988 2024 | Comparative Clinical Study on Magnesium Absorption and Side Effects After Oral Intake of Microencapsulated Magnesium (MAGSHAPE™ Microcapsules) Versus Other Magnesium Sources. Nutrients | Double-blind, randomized, cross-over clinical study in 40 healthy women and men. Participants followed a low-magnesium diet for 7 days and fasted 8 hours, then received a single oral dose of each of four products in cross-over fashion: microencapsulated magnesium (Mg-MS / MAGSHAPE), magnesium oxide (MgO), magnesium citrate (Mg-C), and magnesium bisglycinate (Mg-BG). Blood was drawn by digital puncture before dosing (0 h) and at 1, 4, and 6 hours after each product. | Single-dose exposure per product, not chronic supplementation; sample size n=40; a specific proprietary microencapsulation technology was tested, which may not generalize to other encapsulation methods; plasma magnesium was the only absorption marker used (no urinary or tissue measurement). |
| 29679349 2019 | Timeline (Bioavailability) of Magnesium Compounds in Hours: Which Magnesium Compound Works Best? Biological trace element research | Single-dose administration of 400 mg/70 kg magnesium as one of five compounds (magnesium sulfate, magnesium oxide, magnesium acetyl taurate, magnesium citrate, magnesium malate) to Sprague Dawley rats, with a control group, followed by time-dependent tissue and serum sampling. | Animal model (Sprague Dawley rats), not humans — extrapolation of pharmacokinetic and behavioral findings to people is not established; single dose only, no chronic-dosing data; per-compound group sample size is not stated in the abstract; behavioral endpoints were measured only in rodents. The tested acetyl taurate is distinct from the unmodified taurate in the chemistry table. |
| 29425476 2018 | Scottsdale Magnesium Study: Absorption, Cellular Uptake, and Clinical Effectiveness of a Timed-Release Magnesium Supplement in a Standard Adult Clinical Population. Journal of the American College of Nutrition | Placebo-controlled study at two clinics in 91 adults; 53 received MagSRT (500 mg dimagnesium malate plus vitamins B6, B12, and folate, dosed as 2 tablets containing 250 mg elemental magnesium) and the remainder received placebo. A subset of 24 MagSRT participants continued the trial to 90 days. | Comparator was placebo only, not a head-to-head comparison against other magnesium salts; the tested product combined dimagnesium malate with B-vitamins and folate, so effects cannot be isolated to the malate salt alone; 90-day follow-up was limited to a subset (n=24) of the original 53 treated participants; outcome included a self-reported symptom questionnaire alongside biochemical markers. |
| 1468087 1992 | Blood and urinary magnesium kinetics after oral magnesium supplements. Clinical therapeutics | Randomized, crossover study in 12 healthy normomagnesemic subjects: a baseline period followed by three separate one-week supplementation trials at 16 mmol/dose — magnesium chloride solution, slow-release magnesium chloride tablets, and magnesium gluconate tablets — with a standardized diet during each trial. | Very small sample (n=12); only two chemical forms tested (chloride in two formulations, plus gluconate); short trial duration per arm (24 hours, with weekly crossover intervals); normomagnesemic (not magnesium-deficient) subjects only. |
| 38608850 2024 | The bioaccessibility and tolerability of marine-derived sources of magnesium and calcium. Methods (San Diego, Calif.) | Two-part study. (1) In vitro digestion (INFOGEST method) comparing solubility of Aquamin-Mg (seawater-derived, 12% magnesium), a commercially available magnesium bisglycinate, and a specific branded magnesium bisglycinate (PrizMAG) during simulated gastric and intestinal digestion phases, with and without co-administered food. (2) A randomized, double-blind, placebo-controlled 12-week study in a small cohort of healthy older adults given a combined Aquamin-Mg/Aquamin-F supplement. | The solubility comparison was performed in vitro (simulated digestion model), not as in vivo human absorption; the human arm assessed tolerability/safety only, not comparative bioavailability; the human cohort was described only as small and limited to older adults, with no numeric sample size given in the abstract. |
| 35041150 2022 | Effects of short-term magnesium supplementation on ionized, total magnesium and other relevant electrolytes levels. Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine | Short-term, 10-day supplementation study in 61 healthy young female adults, comparing three magnesium supplement forms: magnesium oxide (powder/granulate), magnesium citrate, and magnesium carbonate (effervescent tablets). | Healthy young female adults only, no male or older/deficient populations studied; short 10-day intervention with no longer-term follow-up; three specific product formulations were tested, so results may not generalize to other products of the same salts; the abstract does not report the per-arm breakdown of the 61 participants. |
Selection starts with work comparing magnesium preparations or measuring a relevant endpoint for a named magnesium compound. A record must have a traceable PubMed identifier and a readable design and endpoint. The retained set is a curated bibliography, not a claim that every eligible paper has been systematically retrieved. A paper’s presence establishes a published measurement in its stated setting; it does not validate a retail label that uses the same salt name.
We report what a study measured, in whom or in which animals, under what conditions. Urinary excretion, serum magnesium, intracellular magnesium, solubility and isotope tracing are different endpoints. A beaker solubility result remains a beaker result. A rat study remains a rat study. A specific clinical population is named instead of being silently generalized to all readers.
The bibliography and export retain study titles exactly, including the authors’ comparative wording where it forms part of the title. Our own summaries describe the experimental design and observations. We do not turn them into a salt ranking, a product claim, a symptom claim or a personal intake instruction. Where a trial names a broad class such as an amino-acid chelate, the class does not acquire a unique molecular formula through its appearance in a paper.
No absorption percentage is multiplied into EC100. That would combine label chemistry with an endpoint obtained in another setting and produce an apparent precision the inputs do not support. The absorption page and study CSV offer the underlying references; the product’s mass and price arithmetic stay tied to its own declaration.
08 · actual publication boundaries
What we do not publish and why
This release applies 2 source-backed boundaries to reused content as of 2026-09-13: Amazon Associates price-display conditions within that programme, and copyright in expressive material such as photographs and copied descriptions.
| Material or claim | Decision | Basis |
|---|---|---|
| Affiliate purchase links alongside retained prices | No affiliate checkout links or live-offer presentation in these product records. | Amazon Associates imposes programme-specific conditions on price and availability displays. |
| Retailer photographs, copied descriptions and review text | Not republished as our dataset or product content. | Copyright distinguishes factual data from expressive text and images. |
| Candidate prices | Withheld until the publication confidence gate passes. | An identity failure would corrupt the denominator; this is our data-quality rule. |
| An exact salt mass for an unresolved compound or mixture | Replaced by the reason it cannot be computed. | The required elemental fraction or constituent proportions are missing. |
| An overall cheapest-salt ranking | Price comparisons stay within a salt. | Different elemental fractions change the question being answered. |
| A factual version-change story from a version count | Only the count and source link are shown. | A count does not contain dates, ingredient changes or a sequence of events. |
Amazon’s policy says a site “may only show prices and availability if” its stated display conditions are met. Those conditions concern Amazon-served links or pricing obtained through the specified programme APIs and used under their licence. This is an Associates programme condition, not a general ban on reporting historical prices. Our retained observations are dated analytical inputs; the cards do not present affiliate links or current purchase offers. Amazon Associates Program Policies.
The U.S. Copyright Office states: “Copyright does not protect facts, ideas, systems, or methods of operation”. Its guidance distinguishes those facts from protected expression, including photographs. We publish our calculations and source facts, and link to the NIH scan rather than treating a retailer’s photograph or sales copy as an openly licensed asset. U.S. Copyright Office: What Does Copyright Protect?
These grounds are not extended into invented prohibitions. The package’s filed serving count, arithmetic days, cost per label-day, same-salt benchmark and linked study findings are published where their inputs exist. Each is identified by its evidence tier and basis. A missing datum is handled as a missing datum, not as a legal restriction.
The DSLD API guide states that its data are in the public domain and requests source acknowledgement. Our attribution identifies NIH Office of Dietary Supplements, Dietary Supplement Label Database, the label identifier and the retained snapshot date. Our own derivative selection, calculations and explanatory text are released under CC BY 4.0; that licence does not relicense unrelated third-party photographs or journal articles.
09 · where the inputs stop
Known limitations
The retained dataset has 297 labels without a resolved single salt and 74 stored price records across 716 labels as of 2026-09-13; only 74 stored prices explicitly pass the current confirmed publication gate.
| Limit | Observed extent or mechanism | Consequence |
|---|---|---|
| Unresolved salt | 297 labels | No invented chemical fraction or compound mass; the missing basis is dated on the card. |
| Stored price coverage | 74 price records for 716 labels | This is sparse coverage, not a complete price census of the US market. |
| Current confidence coverage | 74 explicit confirmed records | Older verified and provisional flags remain distinct from the newer confidence field. |
| Mixtures | Constituent proportions are generally absent. | One resolved salt may represent a declared-source hypothesis, not the whole formulation. |
| Name-resolution priority | The selected label row takes priority over enrichment. | A single salt there can coexist with additional salts in the full record; the mass model remains conditional. |
| Approximate capacity | Three standard sizes and one density band | Capsule fit is modelled; tablets and liquids receive no capsule verdict. |
| Retail package identity | Brand, salt and title milligrams do not necessarily establish the pack count. | Confirmed is the stated matcher result, not proof of every package field. |
| Snapshot dates | Registry 2026-08-10; prices retain their own dates. | Neither a rebuild nor this methodology update makes the underlying observations newer. |
| Sampling unit | One retained label per row; several labels can share a brand or retail item. | Percentiles and medians describe label observations, not independent retailers or unique offers. |
| Study coverage | 16 selected papers with heterogeneous endpoints | No pooled absorption factor or cross-study effectiveness score is computed. |
Resolution failure is not the same as a manufacturer failing to name a salt. Our parser can miss a name, a record can lack the relevant text, or the label can list several carriers without proportions. The dated statement on a card concerns the retained data and model. It does not claim that an external record inspected on another date must have the same gap.
The current salt resolver first uses recognized salts in the selected magnesium rows and then falls back to the full record when that first route yields none. This is the existing dataset’s resolution rule. It can resolve a single recognized salt alongside unrecognized words; it can also miss mixture information elsewhere in the record. We expose salt_source and the complete other-ingredient text so that the interpretation can be reviewed.
Values over 1,000 mg per serving are retained as filed and excluded from the existing form-level amount medians. A conspicuous number is not silently repaired. The label download retains it for inspection. For capsule budgets, the selected serving’s unit count is the divisor; variable serving sizes deserve particular attention because the legacy budget uses the minimum count while the per-unit display preserves the hydration interval at that same count.
A benchmark is available only where the same-salt observation group is large enough for the stated threshold. It does not fill missing prices in the exported observed-price columns. The absence remains visible even when a benchmark is useful. Likewise, neighbours are linked outside the product article, so their prices and mass verdicts do not become facts about the current label.
The rest of the site still includes older comparison views whose review-status vocabulary predates the explicit confidence field. This methodology describes the current product and download contract and identifies that legacy boundary instead of claiming that all stored price records have been re-reviewed. Aggregate mass-budget findings remain on the audit page.
10 · dated changes to the measurement contract
Changelog
This methodology records 4 dated stages from the initial 2026-08-10 snapshot through the 2026-09-13 release, distinguishing changes to publication rules from new source observations.
| Date | Change | Practical effect |
|---|---|---|
| 2026-08-10 | Initial label-price release | EC100, dated price observations, label-to-price review flags and publication-field downloads. |
| 2026-09-10 | Scope narrowed around pages with their own calculation. | Introduced priced, derived and registry-only tiers and a brand-density threshold. |
| 2026-09-11 | Salt chemistry, mass budgets, enrichment, PubMed-checked studies and price matching. | Added formula-based compound masses, capsule comparisons, study provenance and the brand-plus-salt search gate; pages carrying dated gaps remained accessible and indexable. |
| 2026-09-13 | Methodology rewritten; label, audit and study datasets published; product evidence expanded. | Added same-salt percentiles, package duration and costs, framed benchmarks, version counts, scan links, neighbouring labels outside the article, and identical visible/JSON-LD measurement values. |
The current release adds a separate confirmed-price publication view without rewriting source JSON or the original product summaries. Download rows and product cards share the same arithmetic and confidence gate. The snapshot identifier stays fixed until the underlying registry snapshot changes; the methodology date marks this documented calculation contract.
For reproduction, start with the label CSV or JSON, retain the snapshot and derivation dates, and join back to NIH DSLD using dsld_id. Use the low and high compound-mass columns as a pair. Filter prices on match_confidence before calculating within-salt statistics. The audit CSV applies only the two published fill-verdict filters; the studies CSV preserves the bibliographic identifiers needed to revisit the original work.